New Haven, Connecticut 06492

  • Stress


There has been a significant increase in the prevalence of stress- and alcohol- related disorders during the COVID-19 pandemic. This project aims to study the impact of COVID-19 related stress on increasing risk of alcohol misuse and relapse in risky social drinkers after digital interventions.

Study summary:

This project aims to study the influence of COVID-19 related stress on increasing risk of alcohol misuse and relapse after digital interventions. This project proposes a digital intervention study using a prospective clinical outcome design with two demographically-matched groups of risky social drinkers (total N=40; equal gender ratio) with high versus low COVID-19 related stress. We will utilize a digital intervention method that combines telehealth- and smartphone app- based interventions, allowing concurrent treatment and daily monitoring in a real-life setting. All participants will receive a 4-week telehealth intervention (two sessions per week) using an intervention that integrates alcohol treatment and breathing-based stress reduction methods. Then, they will be prospectively followed for 30 days to monitor stress, alcohol use, social functioning, and other health-related behaviors via a smartphone app.


Inclusion Criteria: - Heavy or binge drinkers - Either high or low COVID-19 related stress Exclusion Criteria: - Current or past substance use disorder other than mild alcohol, tobacco, marijuana use disorder - Psychiatric disorders except for mood and anxiety disorders - Any significant current medical conditions



Primary Contact:

Principal Investigator
Dongju Seo, PhD
Yale University

Dongju Seo
Phone: 475-202-9849

Backup Contact:


Location Contact:

New Haven, Connecticut 06492
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.